Rockwell Medical Projects FY26 Revenue Between $70M and $75M
RMTI is trading near its 52-week low of $0.78 (3.4% above the low) on elevated volume (3.3× avg).
Summary
Rockwell Medical has provided its financial outlook, projecting fiscal year 2026 revenue to be in the range of $70 million to $75 million. This forward guidance is a critical update for the company, which recently reported a significant 31.8% drop in net sales for 2025 and is currently trading near its 52-week low. The company is also pursuing a reverse stock split to maintain its Nasdaq listing, as outlined in a recent DEF 14A filing. For a micro-cap company with a market capitalization of approximately $32 million, this revenue guidance sets key financial expectations for the coming year and will significantly influence investor sentiment and valuation. Traders will closely assess this guidance against market expectations to determine its impact on the company's operational trajectory and efforts to stabilize its financial position.
At the time of this announcement, RMTI was trading at $0.81 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $31.9M. The 52-week trading range was $0.78 to $2.10. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.